Quality of Life in Patients With Post-Sepsis Syndrome
Key facts
- Who runs it
- Efferon JSC
- Where
- Russia5 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- People taking part
- 300 people, planned
- Started
- 1 Nov 2026
- Expected to end
- 1 Nov 2029
- Type of study
- Observational, 2 groups
- Treatments tested
- Efferon LPS
- Record updated
- 22 October 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (15)Hide the full registry criteria
Who can take part
- Documented episode of sepsis or septic shock requiring hospitalization and treatment in an intensive care unit (ICU)
- Sequential Organ Failure Assessment (SOFA) score ≥4 points during the ICU stay
- Discharge from the ICU and hospital after completion of treatment for sepsis or septic shock
- Montreal Cognitive Assessment (MoCA) score ≥26 points
- Availability for remote follow-up during the 1-year post-sepsis period following hospital discharge
- Ability to participate in remote visits, complete remote questionnaires (PROMIS questionnaire, depression and anxiety rating scales), and transmit them via electronic communication means
- Ability to understand and independently complete patient-reported outcome questionnaires, or to complete them with minimal assistance
- Availability of information regarding whether hemoadsorption with Efferon® LPS was performed during hospitalization for sepsis or septic shock
- Signed informed consent for participation in the study and collection of follow-up data
Who cannot take part
- Severe cognitive impairment, dementia, or other conditions that prevent the participant from understanding the questionnaire items and providing meaningful responses
- Severe mental illness or other psychiatric conditions that, in the Investigator's opinion, may substantially affect the validity or reliability of patient-reported outcomes
- Any other condition or circumstance that, in the Investigator's opinion, may interfere with the participant's ability to comply with study procedures or may compromise the reliability of the study data
- Inability to maintain remote contact with the participant during the follow-up period
- Palliative care status
- Current participation in another clinical study that, in the Investigator's opinion, may affect the quality-of-life or psychological outcomes assessed in this study
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Sepsis
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The aim of the study is to assess health status and quality of life during the post-sepsis period using patient-reported outcome measures. Patients will be classified into two groups according to treatment received during hospitalization for sepsis or septic shock: those who received standard-of-care treatment alone and those who additionally received Efferon® LPS hemoadsorption. The study will compare post-sepsis outcomes between the two groups over a 12-month follow-up period.
The 2 groups in the trial
- Baseline therapy
Patients who received standard therapy for sepsis. RRT or plasma-based therapies, including plasmapheresis or plasma exchange, are permitted.
- Baseline therapy + Efferon LPS
Patients who received Efferon® LPS hemoadsorption during treatment for sepsis, either alone or in combination with renal replacement therapy (RRT). Concomitant plasma-based therapies, including plasmapheresis or plasma exchange, are permitted.
Treatment: Efferon LPS
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Quality of Life in Patients With Post-Sepsis Syndrome: A Multicenter Observational Study
- Criteria questions
- Built from NCT07889804, who can take part
- Record updated
- 22 October 2026